Back
HFA Premium Access

Characteristics of heart failure patients treated with sacubitril/valsartan in the province of Quebec, Canada

Session: Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Ms A. Daoust (Montreal, CA)
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speaker

Ms Alexia Daoust

Novartis Pharmaceuticals Canada Inc., Montreal (Canada)
0 follower

42 more presentations in this session

Endomyocardial injections of autologous mesenchymal stem cell for treatment the patients with non-ischemic cardiomyopathy

Speaker: Professor A. Kurlianskaya (Minsk, BY)

Access
Abstract
Like
Thumbnail

Altered number of apoptotic-modified endothelial cells originated micro vesicles predict phenotypes of heart failure

Speaker: Professor A. Berezin (Salzburg, AT)

Access
Abstract
Slides
Like
Thumbnail

The plastics of atrioventricular valve in patients with chronic heart failure and severe left ventricular dysfunction

Speaker: Doctor O. Shatova (Minsk, BY)

Access
Abstract
Like
Thumbnail

Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction

Speaker: Doctor M. Meyer (Wuppertal, DE)

Access
Abstract
Slides
Like
Thumbnail

Slow and steady wins the race- the managment of tachycardia induced cardiomyopathy

Speaker: Ms C. Farrell (Letterkenny, IE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Ms A. Daoust, Professor A. Kurlianskaya, Professor A. Berezin, Doctor O. Shatova, Doctor M. Meyer...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources